Wu Jingye, Xu Qian, Luan Jie
Department of Ophthalmology, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China.
School of Medicine, Southeast University, Nanjing, Jiangsu, China.
Eur J Ophthalmol. 2021 Sep;31(5):2596-2605. doi: 10.1177/1120672120970111. Epub 2020 Nov 3.
To evaluate the effect and safety of fovea-sparing internal limiting membrane (ILM) peeling (FSIP) for myopic traction maculopathy comparing with that of total ILM peeling (TP).
PubMed, Web of science, Embase, Cochrane, EBSCO and CNKI, published until January 2020, were searched. Postoperative best-corrected visual acuity (BCVA), postoperative central foveal thickness (CFT), the rate of visual improvement and anatomic success were the main outcome parameters, and the secondary outcome parameters were postoperative complications. Random-effects models were chosen in regard with multi-studies. Standard mean difference (SMD) with 95% confidence interval (CI) and odds ratio (OR) were applied as effect sizes of continuous and binomial data, respectively.
Six comparative studies involving 193 eyes were included. Better postoperative BCVA was detected in the FSIP group (SMD = -0.39, 95%CI: -0.69 to -0.09, = 0.01). The FSIP group had a higher rate of vision improvement with statistical significance (OR = 3.86, 95%CI: 1.36 to 10.97, = 0.01). Both surgical methods had similar outcomes for postoperative CFT (SMD = 0.07, 95%CI: -0.27 to 0.40, = 0.70). The FSIP group had a higher rate of anatomic success, though there was no obvious significance (OR = 2.54, 95%CI: 0.96 to 6.74, = 0.06). For the development of postoperative full-thickness macular hole (FTMH), the rate was lower in the FSIP group (OR = 0.18, 95%CI: 0.05 to 0.64, = 0.008).
Vitrectomy with fovea-sparing ILM peeling for myopic traction maculopathy could gain better visual outcomes and decrease incidence of FTMH development, though there was no obvious difference in postoperative CFT and the rate of anatomic success between two groups.
比较保留黄斑中心凹的内界膜(ILM)剥除术(FSIP)与完全ILM剥除术(TP)治疗近视性牵引性黄斑病变的疗效和安全性。
检索截至2020年1月发表在PubMed、Web of science、Embase、Cochrane、EBSCO和CNKI上的文献。术后最佳矫正视力(BCVA)、术后黄斑中心凹厚度(CFT)、视力改善率和解剖学成功率为主要观察指标,术后并发症为次要观察指标。针对多项研究选择随机效应模型。分别采用95%置信区间(CI)的标准平均差(SMD)和比值比(OR)作为连续数据和二项数据的效应量。
纳入6项比较研究,共193只眼。FSIP组术后BCVA更好(SMD = -0.39,95%CI:-0.69至-0.09,P = 0.01)。FSIP组视力改善率更高,差异有统计学意义(OR = 3.86,95%CI:1.36至10.97,P = 0.01)。两种手术方法术后CFT结果相似(SMD = 0.07,95%CI:-0.27至0.40,P = 0.70)。FSIP组解剖学成功率更高,虽无明显差异(OR = 2.54,95%CI:0.96至6.74,P = 0.06)。对于术后全层黄斑裂孔(FTMH)的发生,FSIP组发生率更低(OR = 0.18,95%CI:0.05至0.64,P = 0.008)。
近视性牵引性黄斑病变采用保留黄斑中心凹的ILM剥除术的玻璃体切除术可获得更好的视力结果,并降低FTMH发生的发生率,尽管两组术后CFT和解剖学成功率无明显差异。